ARTICLE | Company News
GlaxoSmithKline, Vanderbilt University deal
February 18, 2013 8:00 AM UTC
GlaxoSmithKline partnered with Vanderbilt to discover, develop and commercialize positive allosteric modulators (PAMs) of the melanocortin 4 receptor (MC4R) to treat severe obesity. GSK will provide ...